Study of efficacy and longevity of immune response to 3rd and 4th doses of COVID-19 vaccines in patients with cancer: a single arm clinical trial

Peer review process

This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.

History

  1. Version of Record published
  2. Accepted Manuscript published
  3. Accepted
  4. Received
  5. Preprint posted

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Astha Thakkar
  2. Kith Pradhan
  3. Benjamin Duva
  4. Juan Manuel Carreno
  5. Srabani Sahu
  6. Victor Thiruthuvanathan
  7. Sean Campbell
  8. Sonia Gallego
  9. Tushar D Bhagat
  10. Johanna Rivera
  11. Gaurav Choudhary
  12. Raul Olea
  13. Maite Sabalza
  14. Lauren C Shapiro
  15. Matthew Lee
  16. Ryann Quinn
  17. Ioannis Mantzaris
  18. Edward Chu
  19. Britta Will
  20. Liise-anne Pirofski
  21. Florian Krammer
  22. Amit K Verma
  23. Balazs Halmos
(2023)
Study of efficacy and longevity of immune response to 3rd and 4th doses of COVID-19 vaccines in patients with cancer: a single arm clinical trial
eLife 12:e83694.
https://doi.org/10.7554/eLife.83694

Share this article

https://doi.org/10.7554/eLife.83694